[ad_1]
Hong Kong, July 30, 2021-(ACN Newswire)-Bio-computing platform company BioMap recently completed a US$100 million Series A financing, and Legend Capital participated in this round of financing. R&D and talent recruitment.
BioMap is positioned as an innovative drug research and development platform driven by a biocomputing engine. It was co-founded by Robin Li in November 2020 and is currently the chairman. BioMap uses advanced computing and biotechnology to draw disease targets and drug design maps, realizing the world’s first original drug. In the future, BioMap will also focus on the field of tumor immune mechanisms,…
The full story on Benzinga.com
[ad_2]
Source link
